Synthro Lab research peptide vialsPeptides20% off peptidesSynthro Lab · Code MIDDLEWAY
Independent nutrition guides
GLP-1 and peptide coverage
Evidence-focused explainers
Dosing, safety, and access context

Latest

New guides from Middleway

WVE-007 (James Bond Peptide): What It Is and Why the Nickname Is Wrong

GLP-1

WVE-007 (James Bond Peptide): What It Is and Why the Nickname Is Wrong

It is not a peptide, and the Bond reference comes from a gene rather than a film. What is genuinely interesting about it is the muscle question.

Petrelintide & Eloralintide: What These Amylin Analogues Are and Where They Stand

GLP-1

Petrelintide & Eloralintide: What These Amylin Analogues Are and Where They Stand

Two once weekly amylin drugs aiming for GLP-1 style weight loss with far less nausea. Both are in trials, neither is available, and the tolerability claim is the point.

NA-931 (Bioglutide): What It Is and How Much of the Claim Is Verified

GLP-1

NA-931 (Bioglutide): What It Is and How Much of the Claim Is Verified

An oral four-receptor agonist would be a genuine advance if it works. Here is what is actually established about it, and what rests on company statements alone.

Humanin Peptide: What It Is, and How Much the Evidence Supports

Peptides

Humanin Peptide: What It Is, and How Much the Evidence Supports

A 24 amino acid peptide encoded inside mitochondrial DNA, discovered in an Alzheimer's screen. Genuinely interesting biology, and almost entirely preclinical evidence.

How to Use Peptides: Dosage, Mixing and Injection, Step by Step

Peptides

How to Use Peptides: Dosage, Mixing and Injection, Step by Step

A practical walkthrough of using research peptides: mixing the vial, converting milligrams to syringe units, injecting subcutaneously, and the errors that cause wrong doses.

Brenipatide: What It Is, Why It Is Monthly, and What Is Not Yet Known

GLP-1

Brenipatide: What It Is, Why It Is Monthly, and What Is Not Yet Known

A once-monthly GLP-1 and GIP agonist aimed at addiction and psychiatric conditions rather than obesity. The strategy is interesting. The efficacy data does not exist yet.

Aleniglipron (GSBR-1290): What It Is and Where the Trials Stand

GLP-1

Aleniglipron (GSBR-1290): What It Is and Where the Trials Stand

Aleniglipron is an oral GLP-1 receptor agonist that is not a peptide at all. What that difference means, what phase 2 showed, and what phase 3 is testing.

Albiglutide (Tanzeum): What It Was and Why It Disappeared

GLP-1

Albiglutide (Tanzeum): What It Was and Why It Disappeared

The once-weekly GLP-1 that worked, sold for three years, and was withdrawn for commercial reasons. What it did, why it lost, and what a patient would take instead.

AICAR Peptide Benefits: What AMPK Activation Actually Delivers

Peptides

AICAR Peptide Benefits: What AMPK Activation Actually Delivers

AICAR activates AMPK and produced striking endurance results in mice. Whether any of that translates to humans is a separate question, and the dose maths is the problem.